Longitudinal gray matter changes in multiple sclerosis—Differential scanner and overall disease‐related effects
暂无分享,去创建一个
Ludwig Kappos | Thomas E. Nichols | Achim Gass | Frederik Barkhof | Thomas E Nichols | Kerstin Bendfeldt | Nicole Mueller-Lenke | Hugo Vrenken | Yvonne Naegelin | Pascal Kuster | Ernst-Wilhelm Radue | Jeroen J G Geurts | Stefan Traud | Stefan J Borgwardt | F. Barkhof | A. Gass | L. Kappos | J. Geurts | H. Vrenken | N. Mueller-Lenke | E. Radue | S. Borgwardt | S. Roosendaal | Y. Naegelin | K. Bendfeldt | P. Kuster | S. Traud | Louis Hofstetter | Stefan D Roosendaal | Louis Hofstetter
[1] Jeffrey A. Cohen,et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.
[2] Claude Lepage,et al. Mapping reliability in multicenter MRI: Voxel‐based morphometry and cortical thickness , 2010, Human brain mapping.
[3] Ludwig Kappos,et al. Spatiotemporal distribution pattern of white matter lesion volumes and their association with regional grey matter volume reductions in relapsing‐remitting multiple sclerosis , 2010, Human brain mapping.
[4] D. Louis Collins,et al. Evaluation of automated techniques for the quantification of grey matter atrophy in patients with multiple sclerosis , 2010, NeuroImage.
[5] L. Kappos,et al. Longitudinal Spatiotemporal Distribution of Gray and White Matter Pathology in Multiple Sclerosis , 2010, American Journal of Neuroradiology.
[6] Ludwig Kappos,et al. Effect of immunomodulatory medication on regional gray matter loss in relapsing–remitting multiple sclerosis—A longitudinal MRI study , 2010, Brain Research.
[7] Heidi Johansen-Berg,et al. Relationships of brain white matter microstructure with clinical and MR measures in relapsing‐remitting multiple sclerosis , 2010, Journal of magnetic resonance imaging : JMRI.
[8] Stefan Klöppel,et al. Intra- and interscanner variability of automated voxel-based volumetry based on a 3D probabilistic atlas of human cerebral structures , 2010, NeuroImage.
[9] D Louis Collins,et al. Regional impact of field strength on voxel‐based morphometry results , 2009, Human brain mapping.
[10] M. Filippi,et al. 250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study , 2009, The Lancet Neurology.
[11] Mara Cercignani,et al. Exploring the relationship between white matter and gray matter damage in early primary progressive multiple sclerosis: An in vivo study with TBSS and VBM , 2009, Human brain mapping.
[12] Marco Battaglini,et al. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis , 2009, Journal of the Neurological Sciences.
[13] Joanna M. Wardlaw,et al. Prospective multi-centre Voxel Based Morphometry study employing scanner specific segmentations: Procedure development using CaliBrain structural MRI data , 2009, BMC Medical Imaging.
[14] David H. Miller,et al. Imaging outcomes for neuroprotection and repair in multiple sclerosis trials , 2009, Nature Reviews Neurology.
[15] Ludwig Kappos,et al. Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis — A longitudinal voxel-based morphometry study , 2009, NeuroImage.
[16] Kunio Nakamura,et al. Segmentation of brain magnetic resonance images for measurement of gray matter atrophy in multiple sclerosis patients , 2009, NeuroImage.
[17] F. Barkhof,et al. Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial , 2008, The Lancet Neurology.
[18] Graeme D. Jackson,et al. Multi-site voxel-based morphometry: Methods and a feasibility demonstration with childhood absence epilepsy , 2008, NeuroImage.
[19] Massimo Filippi,et al. A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes , 2008, NeuroImage.
[20] Clifford R. Jack,et al. Interpreting scan data acquired from multiple scanners: A study with Alzheimer's disease , 2008, NeuroImage.
[21] Paolo Fusar-Poli,et al. Anterior cingulate pathology in the prodromal stage of schizophrenia , 2008, NeuroImage.
[22] Paolo Fusar-Poli,et al. Neurofunctional correlates of vulnerability to psychosis: A systematic review and meta-analysis , 2007, Neuroscience & Biobehavioral Reviews.
[23] Marcus D'Souza,et al. Structural brain abnormalities in individuals with an at-risk mental state who later develop psychosis. , 2007, The British journal of psychiatry. Supplement.
[24] Stephen M. Smith,et al. Regional brain atrophy development is related to specific aspects of clinical dysfunction in multiple sclerosis , 2007, NeuroImage.
[25] R. Woods,et al. Sex differences in cortical thickness mapped in 176 healthy individuals between 7 and 87 years of age. , 2007, Cerebral cortex.
[26] Philip K. McGuire,et al. Regional Gray Matter Volume Abnormalities in the At Risk Mental State , 2007, Biological Psychiatry.
[27] Rohit Bakshi,et al. Gray matter involvement in multiple sclerosis , 2007, Neurology.
[28] Alan C. Evans,et al. Focal cortical atrophy in multiple sclerosis: Relation to lesion load and disability , 2007, NeuroImage.
[29] Alan J. Thompson,et al. Localization of grey matter atrophy in early RRMS , 2006, Journal of Neurology.
[30] Ludwig Kappos,et al. Oral fingolimod (FTY720) for relapsing multiple sclerosis. , 2006, The New England journal of medicine.
[31] Mara Cercignani,et al. Regional gray matter atrophy in early primary progressive multiple sclerosis: a voxel-based morphometry study. , 2006, Archives of neurology.
[32] F. Jessen,et al. Multicenter assessment of reliability of cranial MRI , 2006, Neurobiology of Aging.
[33] Anders M. Dale,et al. Reliability of MRI-derived measurements of human cerebral cortical thickness: The effects of field strength, scanner upgrade and manufacturer , 2006, NeuroImage.
[34] Clifford R Jack,et al. Common MRI acquisition non-idealities significantly impact the output of the boundary shift integral method of measuring brain atrophy on serial MRI , 2006, NeuroImage.
[35] Anders M. Dale,et al. Reliability in multi-site structural MRI studies: Effects of gradient non-linearity correction on phantom and human data , 2006, NeuroImage.
[36] Bruno Alfano,et al. Grey matter loss in relapsing–remitting multiple sclerosis: A voxel-based morphometry study , 2006, NeuroImage.
[37] Arthur W. Toga,et al. Impact of acquisition protocols and processing streams on tissue segmentation of T1 weighted MR images , 2006, NeuroImage.
[38] S. Reingold,et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.
[39] Stephen Lawrie,et al. Empirical comparison of maximal voxel and non-isotropic adjusted cluster extent results in a voxel-based morphometry study of comorbid learning disability with schizophrenia , 2005, NeuroImage.
[40] Cheryl L. Dahle,et al. Regional brain changes in aging healthy adults: general trends, individual differences and modifiers. , 2005, Cerebral cortex.
[41] G Tedeschi,et al. Brain atrophy and lesion load in a large population of patients with multiple sclerosis , 2005, Neurology.
[42] Zhengrong Liang,et al. Partial volume segmentation of brain magnetic resonance images based on maximum a posteriori probability. , 2005, Medical physics.
[43] Hans Lassmann,et al. Cortical lesions and brain atrophy in MS , 2005, Journal of the Neurological Sciences.
[44] A J Thompson,et al. Gray and white matter volume changes in early RRMS , 2005, Neurology.
[45] M. Rovaris,et al. Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype. , 2005, AJNR. American journal of neuroradiology.
[46] D. Louis Collins,et al. Relating neocortical pathology to disability progression in multiple sclerosis using MRI , 2004, NeuroImage.
[47] Thomas E. Nichols,et al. Nonstationary cluster-size inference with random field and permutation methods , 2004, NeuroImage.
[48] David H. Miller,et al. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. , 2004, Brain : a journal of neurology.
[49] A. Dale,et al. Focal thinning of the cerebral cortex in multiple sclerosis. , 2003, Brain : a journal of neurology.
[50] P. M. Matthews,et al. Evidence of early cortical atrophy in MS , 2003, Neurology.
[51] Bruno Alfano,et al. Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load , 2003, NeuroImage.
[52] A J Thompson,et al. Brain atrophy in clinically early relapsing-remitting multiple sclerosis. , 2002, Brain : a journal of neurology.
[53] Ari Syngeniotis,et al. Comparison of Hippocampal Volumetry at 1.5 Tesla and at 3 Tesla , 2001, Epilepsia.
[54] Karl J. Friston,et al. A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains , 2001, NeuroImage.
[55] N. Andreasen,et al. Anatomic and Functional Variability: The Effects of Filter Size in Group fMRI Data Analysis , 2001, NeuroImage.
[56] Karl J. Friston,et al. Voxel-Based Morphometry—The Methods , 2000, NeuroImage.
[57] G Schwemer,et al. General linear models for multicenter clinical trials. , 2000, Controlled clinical trials.
[58] Alan C. Evans,et al. Three-Dimensional MRI Atlas of the Human Cerebellum in Proportional Stereotaxic Space , 1999, NeuroImage.
[59] J. Ashburner,et al. Nonlinear spatial normalization using basis functions , 1999, Human brain mapping.